Misplaced Pages

Pamlab

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
American medical food company
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
This article includes a list of general references, but it lacks sufficient corresponding inline citations. Please help to improve this article by introducing more precise citations. (June 2014) (Learn how and when to remove this message)
The topic of this article may not meet Misplaced Pages's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted.
Find sources: "Pamlab" – news · newspapers · books · scholar · JSTOR (June 2015) (Learn how and when to remove this message)
(Learn how and when to remove this message)

Alfasigma USA, Inc. (formerly Pamlab) is an American medical food company, and a division of Alfasigma Group, of Bologna, Italy.

Alfasigma's base of operations is located in Bedminster, New Jersey.

History

The company entered the pharmaceutical industry in 1957, initially introducing prescription cough/cold products. In 1987, Pamlab was purchased by Samuel and Judith Camp.

In early 2013, Pamlab was purchased by Nestlé Health Science.

In December 2016, Pamlab was purchased by Alfasigma Group of Bologna, Italy.

Legal actions

Alfasigma USA, Inc. was sued by ExeGi Pharma LLC and the Italian inventor of probiotic VSL#3, Claudio De Simone, for making false advertising claims and ownership rights to VSL#3.

According to court documents: "Defendant VSL Inc., and its licensees Alfasigma and Leadiant, having lost the right to sell the De Simone Formulation, decided to manufacture, market, and sell a different, inferior formulation (the “Fraudulent Formulation”) without conducting any tests to determine if the Fraudulent Formulation would be efficacious in any way".  

A scientific article published in Frontiers in Immunology concluded: "These discrepancies may have a major impact on patient safety and on the liability of doctors when they prescribe a probiotic formulation made with different processes at different production sites from the formulation, which generated the original evidence, without properly informing the patients".

A class action related to the VSL#3 scandal was recently opened in the USA.

Products

Alfasigma USA, Inc. produces medical foods for people with diabetic peripheral neuropathy, early memory loss/Alzheimer's, high-risk pregnancy, depression, and other medical conditions.

Some of Alfasigma USA's products include the following:

See also

References

  1. "Our History". Pamlab. Retrieved 2016-03-24.
  2. "Nestle buys U.S. medical foods firm Pamlab". Reuters. 26 February 2013. Retrieved 2016-03-24.
  3. "Alfasigma Expands Footprint" (PDF). 13 January 2017. Archived from the original (PDF) on 22 December 2018. Retrieved 18 July 2017.
  4. Simone, C. De (2018). "Letter: what gastroenterologists should know about VSL#3". Alimentary Pharmacology & Therapeutics. 47 (5): 698–699. doi:10.1111/apt.14515. ISSN 1365-2036. PMID 29417631.
  5. "De Simone v. VSL Pharmaceuticals, Inc. et al, No. 8:2015cv01356 - Document 927 (D. Md. 2019)". Justia Law. Retrieved 2019-09-01.
  6. ^ "Class Action" (PDF).
  7. Trinchieri, Vito; Laghi, Luca; Vitali, Beatrice; Parolin, Carola; Giusti, Ilaria; Capobianco, Daniela; Mastromarino, Paola; De Simone, Claudio (2017-11-06). "Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing". Frontiers in Immunology. 8: 1474. doi:10.3389/fimmu.2017.01474. ISSN 1664-3224. PMC 5681494. PMID 29163538.
  8. "Class Action Accuses Pharma Companies of Secretly Reformulating VSL#3 Probiotics Product". www.classaction.org. 26 July 2019. Retrieved 2019-09-01.

External links

Nestlé
Divisions
Divested
Subsidiaries
Joint ventures
Other assets
Brands
Appliances
Baby nutrition
Baking
Bottled water
Cereals
Chocolate
and desserts
Coffee and
beverages
Dairy products
Ice cream
Prepared and
packaged food
and snacks
Purina PetCare
Uncle Tobys
Former brands and
subsidiaries
People
Related
Related articles
  • Currently manufactured by General Mills in the U.S. and Canada. Produced by Cereal Partners under the Nestlé brand elsewhere. Brand owned by General Mills; U.S. and Canadian production rights controlled by Nestlé under license. U.S. production rights owned by The Hershey Company. U.S. rights and production owned by the Smarties Candy Company with a different product. U.S. rights and specific trade dress owned by Nestlé; rights elsewhere owned by Associated British Foods. Produced by Cereal Partners, branded as Nestlé. Produced by Cereal Partners and branded as Nestlé in the U.K. and Ireland. Produced by Post Foods elsewhere. Philippine production rights owned by Alaska Milk Corporation. Singaporean, Malaysian and Thai production rights owned by Fraser and Neave. Used only in Indonesia, Thailand, and Cambodia. Used only in the Philippines. U.S. production rights owned by the Ferrara Candy Company. NA rights and specific trade dress to all packaged coffee and other products under the Starbucks brand owned by Nestlé since 2019. Brand owned by Mars, sold by Nestlé in Canada. Produced by Froneri in the U.S. since 2020.


Stub icon

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This corporation or company article is a stub. You can help Misplaced Pages by expanding it.

Categories: